Table 1.
No of Patients | Images Phase/ROI/Sofware | Type RF | RF Correlated with G | |
---|---|---|---|---|
D’Onofiro et al., 2019 [84], Sci Rep | 100 | Pancreatic 2D ROI 1 slice MaZda 4.6 |
1st order | Kurtosis and entropy |
Guo et al., 2018 [79], Abdo Imaging | 37 | Arterial 2D Five slices Matlab 2014a |
1st order | Mean grey level intensity |
Canellas et al., 2018 [81], AJR | 101 | Portal TextRad 2D ROI |
1st order | Entropy |
Choi et al., 2018 [82], Acta Radiol | 66 | Arterial + portal 2D ROI |
1st order | Sphericity, skewness, kurtosis |
Gu et al., 2018 [80], Eur Radiol | 104 training 34 validation |
Arterial and portal 3D ROI Pyradiomics 1.3.0 |
1st, 2nd, and 3rd order radiomics signature: 15 arterial RF + 10 portal RF from 853 RF | Radiomics signature on arterial + portal images Nomagram: Radiomics + tumor margin |
Liang et al., 2019 [83], Clin Cancer Res | 86 training 51 validation |
Arterial 3D ROI In-house software |
1st, 2nd, and 3rd order radiomics signature 8RF from 467 RF |
Monogram: Radiomics signature on arterial + clinical stage |
MRI-based radiomics in prostate cancer und neuroendocrine tumors.